CytoMed Therapeutics Ltd

Listed Company
GDTCCIK 0001873093NasdaqNon-AcceleratedEmerging GrowthPharmaceutical PreparationsU0SGFY ends Dec 31
Period
FY 2025
Revenue
—
Net Income
$-3.11M
Total Assets
$6.21M
Equity
—
Shares Out
11.83M
Op. Cash Flow
—
GDTC$0.98−55.07% · past yearDBEQ Basic
Daily closing prices

Business

CytoMed Therapeutics Ltd is a clinical-stage biopharmaceutical company developing allogeneic cell-based immunotherapies for cancer using gamma delta T cells, natural killer cells, and induced pluripotent stem cells. Lead candidate CTM-N2D is a CAR-grafted gamma delta T cell therapy in Phase I trials. The company manufactures products in its own cGMP facility in Malaysia, licenses core technology from A*STAR Singapore, and operates subsidiaries in Malaysia and Singapore.

Summary from 20-F filed 2026-03-31

Financials

Latest annual snapshot (FY2025, period end 2025-12-31). Full statement history unavailable for this entity.

Revenue—
Net income$-3.11M
Total assets$6.21M
Total liabilities$879.8K
Stockholders' equity—
Operating cash flow—

Filings

Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro

Material Events

Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro

Insiders

Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro

Institutional Holders

Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro

Frequently asked questions

What is CytoMed Therapeutics Ltd's CIK number?

CytoMed Therapeutics Ltd's SEC CIK number is 0001873093 (1873093). The CIK (Central Index Key) is the permanent identifier the SEC assigns to every EDGAR filer — unlike a ticker symbol, it never changes.

Where can I find CytoMed Therapeutics Ltd's SEC filings?

All of CytoMed Therapeutics Ltd's EDGAR filings — 10-K annual reports, 10-Q quarterly reports, 8-K material events, and insider transactions — are listed on this page, sourced live from SEC EDGAR.

Look up any company's CIK number →